Riskpilot← Back to searchSign inGet full accessOftaderma Oy
OYActiveY-tunnus 2311253-1Haukkalantie 48Medical specialists activities · NACE 8622Est. 20102 employees
Revenue 2024
EUR 687K
+13% vs 2023
EBITDA margin
52.5%
+19% vs 2023
Equity ratio
66.9%
Financial strength
Net profit 2024
EUR 290K
+19% vs 2023
| Revenue | EUR 687K | +13% |
| EBITDA | EUR 361K | +19% |
| Net profit | EUR 290K | +19% |
| Total assets | EUR 43,6M | -55% |
| Equity | EUR 29,2M | -66% |
| Employees | 2 | — |
Legal name
Oftaderma Oy
Y-tunnus number
2311253-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
15. tammikuuta 2010
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimiala on tarjota lääkäripalveluita ja konsultaatioita, lääketieteen- ja lääkealan koulutusta ja tutkimustoimintaa ja tuotekehitystä ja laitekauppaa. Yhtiö voi toimintaansa varten ostaa, myydä ja hallita asunto-, kiinteistö-, pörssiyhtiöiden ja/tai muiden yhtiöiden osakkeita sekä kiinteistöjä, sekä muita sijoitusinstrumentteja.
Address
Haukkalantie 48
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 410 | 465 | 493 | 506 | 530 | 609 | 687 |
| Staff expenses | −217 | −217 | −212 | −198 | −198 | −200 | −2 656 |
| EBITDA | 131 | 159 | 190 | 217 | 236 | 302 | 361 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −1 | −4 |
| EBIT | 131 | 159 | 190 | 217 | 236 | 302 | 484 |
| Net financials | 5 | — | −0 | −0 | −5 | 5 | 0 |
| Profit before tax | 136 | 159 | 190 | 217 | 231 | 307 | 360 |
| Tax | 27 | 32 | 38 | 44 | 47 | 62 | 70 |
| Net profit | 109 | 127 | 152 | 174 | 183 | 244 | 290 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 488 | 586 | 694 | 815 | 932 | 96 130 | 43 634 |
| Equity | 478 | 567 | 673 | 793 | 913 | 85 830 | 29 172 |
| Long-term debt | — | — | — | — | — | 0 | 0 |
| Short-term debt | 10 | 19 | 21 | 22 | 19 | 33 | 35 |
| Total debt | 10 | 19 | 21 | 22 | 19 | 33 | 35 |
EBITDA margin
52.5%
This company
15.8%
Market median
+232% vs market
20182024
Equity ratio
66.9%
This company
38.2%
Market median
+75% vs market
20182024
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20182024
Net profit margin
42.2%
This company
8.1%
Market median
+421% vs market
20182024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20182024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ME Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
OK Deputy Member | Deputy Member | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2010 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oftaderma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Elina Laine | Chief Executive Officer | 0 companies |
| Orvo Kalevi Laine | Deputy Member | 0 companies |
| Juhana Kalevi Laine | Chairperson | 0 companies |